For Investors

Press Releases

ReWalk Robotics Reports First Quarter 2016 Financial Results

05/05/16

-Growth driven by U.S. Veterans Administration and Commercial Insurance Reimbursement- YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , May 05, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) today announced its financial results for the three-month period ended

Read More
Read More

ReWalk Robotics to Discuss 2016 First Quarter Financial Results on May 5, 2016 Conference Call

04/25/16

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., April 25, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK ), the leading global exoskeleton developer and manufacturer, will release its 2016 first quarter financial results on Thursday, May 5, 2016, before the U.S. financial markets open.

Read More
Read More

First-Ever Meta-Analysis of Exoskeleton Technologies Concludes Powered Exoskeleton Systems Permit Safe Ambulation in Real-Life Settings and Produce Health Benefits

04/20/16

Upon completion of exoskeleton system training, 76% of documented subjects were able to walk independently without any additional human assistance YOKNEAM ILIT, Israel and BERLIN and MARLBOROUGH, Mass. , April 20, 2016 /PRNewswire-USNewswire/ -- ReWalk Robotics Ltd.

Read More
Read More

ReWalk Robotics Appoints Peter L. Wehrly to its Board of Directors

04/05/16

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , April 05, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or the “Company”), the leading global exoskeleton developer and manufacturer, today announced that Peter L. Wehrly , a seasoned medical device industry veteran with over 25

Read More
Read More

ReWalk Robotics to Present at Barclays Global Healthcare Conference

03/23/16

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , March 10, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“Rewalk” or “the Company”) (Nasdaq:RWLK) today announced that Larry Jasinski , Chief Executive Officer, and Kevin Hershberger , Chief Financial Officer, will present at the Barclays Global

Read More
Read More

ReWalk Robotics Reports Fourth Quarter and Year-End 2015 Financial Results

02/25/16

Record 23 Personal Units Placed During the Fourth Quarter YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 25, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) today announced its financial results for the three- and twelve-month periods ended December 31,

Read More
Read More

German Social and Youth Agency Reimburses ReWalk Robotics Exoskeleton for the First Time

02/24/16

Agency Approved Reimbursement for ReWalk on Appeal, Reversing Initial Denial YOKNEAM ILIT, Israel , BERLIN and MARLBOROUGH, Mass. , Feb. 24, 2016 /PRNewswire/ --  ReWalk Robotics Ltd. (Nasdaq: RWLK) and ReWalk Robotics d.b.a. Argo Medical Technologies GmbH ("ReWalk" or "Company"), the leading

Read More
Read More

ReWalk Robotics Exoskeleton Deemed Medically Necessary by Independent Medical Review Organization

02/16/16

Recipient is a surgeon whose exoskeleton will allow him to stand and walk at home and at work YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 16, 2016 /PRNewswire/ --  ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or "Company"), the leading global exoskeleton developer and manufacturer,

Read More
Read More

ReWalk Robotics to Discuss 2015 Fourth Quarter and Full Year Financial Results on February 25, 2016 Conference Call

02/04/16

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 04, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK), the leading global exoskeleton developer and manufacturer, will release its 2015 fourth quarter and full year financial results on Thursday, February 25, 2016 , before the U.S.

Read More
Read More

ReWalk Featured in Details of Department of Veterans Affairs' National Multi-Center Clinical Exoskeleton Trial

02/03/16

Six ReWalk Exoskeleton Systems Have Been Shipped for the Initial Phase of Four-Year VA Study YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Feb. 3, 2016 /PRNewswire/ --  ReWalk Robotics Ltd.  (Nasdaq: RWLK) ("ReWalk" or "Company"), the leading global exoskeleton developer and manufacturer,  announced

Read More
Read More

Peer-Reviewed Case Study Demonstrates Various Health Improvements Following ReWalk Exoskeleton Use

01/27/16

Study Offers Key Evidence for Healthcare Providers, Development of Procurement Policies for Eligible Users YOKNEAM ILIT, Israel , BERLIN and MARLBOROUGH, Mass. , Jan. 27, 2016 /PRNewswire/ --  ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk"), the leading global exoskeleton developer and manufacturer,

Read More
Read More

Department of Veterans Affairs Purchases Six ReWalk Robotics Exoskeleton Systems for National Multi-Center Clinical Trial

01/11/16

Four-Year Study Will Assess Impacts of Exoskeleton Use in Home/Community Setting on Patient Health & Well-Being YOKNEAM ILIT, Israel and MARLBOROUGH, MA-- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”) , the leading global exoskeleton developer and manufacturer, announced

Read More
Read More
Displaying 241 - 252 of 304